Pernille Trøjgaard has more than 20 years of clinical research experience and has spent the last 15+ years focusing on clinical trials and clinical development programs within medical device development. Furthermore, she has worked with the development of tools to improve endpoint measurement including data management aspects. She is currently Director of Clinical Operations at Coloplast A/S where she is responsible for the clinical studies conducted in relation to the clinical development programs within Continence Care, Ostomy Care and Wound Care. Previously she has worked at Merck Sharp & Dohme (MSD) and Parexel responsible for the conduct and oversight of clinical trials. Pernille Trøjgaard has a Master of Science in Pharmacy from the University of Copenhagen, Denmark.